Where is Mitra Bio located?

Mitra Bio is headquartered in London, United Kingdom. It is registered at Central Working White City Translation And Innovation Hub, 84 Wood Lane, London, England, W12 0B.

Which legal entities is Mitra Bio associated with?

Mitra Bio is associated with MITRA BIO LIMITED.

How many employees does Mitra Bio have?

As of Apr 30, 2022, the latest employee count at Mitra Bio is 3.

Is Mitra Bio a funded company?

Mitra Bio is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Mitra Bio rank among its competitors?

Mitra Bio ranks 15th amongst 26 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Arima Genomics, which secured $22M in Jun, 2025.

Who are the top competitors of Mitra Bio?

Mitra Bio's top competitors include Arima Genomics, Oxford Biodynamics and ADmit Therapeutics. Among them, Arima Genomics secured the most recent funding round in June, 2025.

Mitra Bio - 2026 Company Profile, Funding & Competitors

Company Details

Developer of genetic and epigenetic discovery platform for skin ageing. The company uses genetic and epigenetic biomarker data derived from skin-patches which help to develop therapeutics to fight the root cause of skin ageing.

Website: mitrabio.tech
Email ID: *****@mitrabio.tech
Registered Address: Central Working White City Translation And Innovation Hub, 84 Wood Lane, London, England, W12 0B

Key Metrics

Founded Year

2020

Location

London, United Kingdom

Stage

Funding Raised

Investors

Entrepreneur First & 4 more

Ranked

15^th among 26 active competitors

Employee Count

3 as on Apr 30, 2022

Similar Companies

Arima Genomics & 39 more

View Mitra Bio's full profile

Mitra Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MITRA BIO LIMITED CIN: 12542435 , United Kingdom, Active	Mar 31, 2020	-	6 (As on Apr 30, 2025)

Mitra Bio is a funded company. Mitra Bio has 5 institutional investors.

View details of Mitra Bio's funding rounds and investors

Mitra Bio's employee count trend

Mitra Bio has 3 employees as of Apr 22. The total employee count is 50.0% more than what it was in Apr 21. Here is Mitra Bio's employee count trend over the years:

Uncover Mitra Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mitra Bio include Arima Genomics, Oxford Biodynamics and ADmit Therapeutics. Here is the list of Top 10 competitors of Mitra Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Arima Genomics 2015, San Diego (United States), Series C	Developer of technologies for genome sequence and structure	$29M	Illumina Ventures, Ladder Ventures & 10 others	57/100
2nd	Oxford Biodynamics 2007, Oxford (United Kingdom), Public	Developer of personalized diagnostics by identifying biomarkers through epigenetics	$11M	Armistice Capital, Oxford University Innovation ... & 1 others	57/100
3rd	ADmit Therapeutics 2017, Barcelona (Spain), Series A	Provider of diagnostic services for early detection of Alzheimer's disease	$12.9M	Ship2B, Bstartup Banco Sabadell & 13 others	57/100
4th	Sherlock 2019, Watertown (United States), Acquired	Provider of a diagnostic platform for DNA and RNA detection	$111M	Baidu Ventures, Novalis LifeSciences & 11 others	54/100
5th	Tagomics 2020, Birmingham (United Kingdom), Series A	Developer of genomic-based cancer diagnostic platform	$8.45M	Calculus Capital, Illumina Ventures & 7 others	51/100
6th	Age Labs 2017, Oslo (Norway), Seed	Developer of molecular diagnostic solutions for the detection of age-related diseases	$876K	Skyfall Ventures, Aleap & 2 others	50/100
7th	Oncgnostics 2012, Jena (Germany), Public	Developer of epigenetic biomarkers for cancer detection and diagnosis	$1.42M	HTGF, Beteiligungsmanagement Thuringen & 13 others	45/100
8th	OncoMethylome 2003, Antwerp (Belgium), Series B	Diagnostics for early detection of cancer	$33.9M	Edmond de Rothschild, Life Sciences Partners ... & 4 others	44/100
9th	Genomic Testing Cooperative 2018, Irvine (United States), Funding Raised	Provider of DNA and RNA profiling of hematologic neoplasms and solid tumors	-	-	43/100
10th	Inherent Biosciences 2019, Salt Lake City (United States), Series A	Developer of epigenetic diagnostics and therapeutics for complex diseases	-	morningstar.foundation, Propel Bio Partners ... & 12 others	37/100
15th	Mitra Bio 2020, London (United Kingdom), Funding Raised	Developer of genetic and epigenetic discovery platform for skin ageing	-	Entrepreneur First, Merian Ventures & 3 others	28/100